Skip to main content Accessibility help

The effect of ‘Zesy002’ kiwifruit (Actinidia chinensis var. chinensis) on gut health function: a randomised cross-over clinical trial

  • Sarah L. Eady (a1), Alison J. Wallace (a1), Christine A. Butts (a2), Duncan Hedderley (a2), Lynley Drummond (a3), Juliet Ansell (a4) and Richard B. Gearry (a5)...


Functional gastrointestinal disorders including constipation affect up to 14 % of the world's population. Treatment is difficult and challenging resulting in a need for alternative safe and effective therapies. The present study investigated whether daily consumption of three gold-fleshed kiwifruit could alleviate constipation and improve gastrointestinal discomfort in mildly constipated individuals with and without pain. A total of thirty-two participants were enrolled in a 16-week randomised, single-blind, crossover study. Participants received either three ‘Zesy002’ kiwifruit or 14·75 g Metamucil® (5 g dietary fibre/d (a positive control)) for 4 weeks each with a 4-week washout between treatments. A 2-week washout period was included at the beginning and end of the study. Daily bowel habit diaries were kept throughout the study. The primary outcome measure was differences in the number of complete spontaneous bowel movements (CSBM). Secondary outcome measures were bowel movement frequency and stool form as well as digestive symptoms and comfort. The number of CSBM per week was significantly greater during daily consumption of three kiwifruit compared with the baseline (6·3 v. 3·3; P < 0·05) and the Metamucil® treatment (6·3 v. 4·5; P < 0·05). Stool consistency was also improved, with kiwifruit producing softer stools and less straining (P < 0·05). Gastrointestinal discomfort was also improved compared with baseline for abdominal pain, constipation and indigestion (P < 0·05) during the kiwifruit intervention and constipation during the Metamucil® intervention (P < 0·05). This randomised controlled trial demonstrates that daily consumption of three gold-fleshed kiwifruit is associated with a significant increase of two CSBM per week and reduction in gastrointestinal discomfort in mildly constipated adults.

  • View HTML
    • Send article to Kindle

      To send this article to your Kindle, first ensure is added to your Approved Personal Document E-mail List under your Personal Document Settings on the Manage Your Content and Devices page of your Amazon account. Then enter the ‘name’ part of your Kindle email address below. Find out more about sending to your Kindle. Find out more about sending to your Kindle.

      Note you can select to send to either the or variations. ‘’ emails are free but can only be sent to your device when it is connected to wi-fi. ‘’ emails can be delivered even when you are not connected to wi-fi, but note that service fees apply.

      Find out more about the Kindle Personal Document Service.

      The effect of ‘Zesy002’ kiwifruit (Actinidia chinensis var. chinensis) on gut health function: a randomised cross-over clinical trial
      Available formats

      Send article to Dropbox

      To send this article to your Dropbox account, please select one or more formats and confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your <service> account. Find out more about sending content to Dropbox.

      The effect of ‘Zesy002’ kiwifruit (Actinidia chinensis var. chinensis) on gut health function: a randomised cross-over clinical trial
      Available formats

      Send article to Google Drive

      To send this article to your Google Drive account, please select one or more formats and confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your <service> account. Find out more about sending content to Google Drive.

      The effect of ‘Zesy002’ kiwifruit (Actinidia chinensis var. chinensis) on gut health function: a randomised cross-over clinical trial
      Available formats


This is an Open Access article, distributed under the terms of the Creative Commons Attribution licence (, which permits unrestricted re-use, distribution, and reproduction in any medium, provided the original work is properly cited.

Corresponding author

*Corresponding author: Sarah L. Eady, email


Hide All
1.Lacy, BE, Mearin, F, Chang, L, et al. (2016) Bowel disorders. Gastroenterology 150, 13931407.
2.Schmulson, MJ & Drossman, DA (2017) What is new in Rome IV? J Neurogastroenterol Motil 23, 151163.
3.Suares, NC & Ford, AC (2011) Prevalence of and risk factors for chronic idiopathic constipation in the community: a systematic review and meta-analysis. Am J Gastroenterol 106, 15821591.
4.Enck, P, Lenert, J, Smid, M, et al. (2016) Functional constipation and constipation – predominant irritable bowel syndrome in the general population: data from the GECCO study. Gastroenterol Res Pract 2016, 3186016.
5.Mugie, SM, Benninga, MA & Di Lorenzo, C (2011) Epidemiology of constipation in children and adults: a systematic review. Best Pract Res Clin Gastroenterol 25, 318.
6.Lindberg, G, Hamid, SS, Malfertheiner, P, et al. (2011) World Gastroenterology Organisation global guideline: Constipation – a global perspective. J Clin Gastroenterol 45, 483487.
7.Schmidt, FMQ & De Gouveia Santos, VLC (2014) Prevalence of constipation in the general adult population: an integrative review. J Wound Ostomy Continence Nurs 41, 7076.
8.Ashraf, W, Park, F, Lof, J, et al. (1995) Effects of psyllium therapy on stool characteristics, colon transit and anorectal function in chronic idiopathic constipation. Aliment Pharmcol Ther 9, 639647.
9.McRorie, JW, Daggy, BP, Morel, JG, et al. (2005) Psyllium is superior to docusate sodium for treatment of chronic constipation. Aliment Pharmacol Ther 12, 491497.
10.Ramkumar, D & Rao, SS (2005) Efficacy and safety of traditional medical therapies for chronic constipation: systematic review. Am J Gastroenterol 100, 936971.
11.Schiller, LR (2001) Review article: the therapy of constipation. Aliment Pharmacol Ther 15, 749763.
12.Attaluri, A, Donahoe, R, Valestin, J, et al. (2011) Randomised clinical trial: dried plums (prunes) vs. psyllium for constipation. Aliment Pharmacol Ther 33, 822828.
13.Bayer, SB, Gearry, RB & Drummond, LN (2017) Putative mechanisms of kiwifruit on maintenance of normal gastrointestinal function. Crit Rev Food Sci Nut 58, 24322452.
14.Chan, A, Leung, G, Tong, T, et al. (2007) Increasing dietary fibre intake in terms of kiwifruit improves constipation in Chinese patients. World J Gastroenterol 13, 47714775.
15.Udani, JK & Bloom, DW (2013) Effects of kivia powder on gut health in patients with occasional constipation: a randomised double-blind, placebo-controlled study. Nutr J 12, 78.
16.Rush, EC, Patel, M, Plank, LD, et al. (2002) Kiwifruit promotes laxation in the elderly. Asia Pac J Clin Nutr 11, 164168.
17.Chang, CC, Lin, YT, Lu, YT, et al. (2010) Kiwifruit improves bowel function in patients with irritable bowel syndrome with constipation. Asia Pac J Clin Nutr 19, 451457.
18.Kindleysides, S, Kuhn-Sherlock, B, Yip, W, et al. (2015) Encapsulated green kiwifruit extract: a randomised controlled trial investigating alleviation of constipation in otherwise healthy adults. Asia Pac J Clin Nutr 24, 421429.
19.Zespri (2016) Zespri Varieties. (accessed January 2016).
20.Francis, CY, Morris, J & Whorwell, KK (1997) The Irritable Bowel Severity Scoring System: a simple method of monitoring IBS and its progress. Aliment Pharmacol Ther 11, 395402.
21.Svedlund, J, Sjodin, I & Dotevall, G (1988) GSRS: a clinical rating scale for gastrointestinal symptoms in patients with irritable bowel syndrome and peptic ulcer disease. Dig Dis Sci 33, 129134.
22.Lee, W, Hamernyik, P, Hutchinson, M, et al. (1982) Ascorbic acid in lymphocytes: cell preparation and liquid chromatography assay. Clin Chem 28, 21652169.
23.Johanson, JF, Wald, A, Tougas, G, et al. (2004) Effect of tegaserod in chronic constipation: a randomized double-blind, controlled trial. Clin Gastroenterol Hepatol 2, 796805.
24.Leung, L, Riutta, T & Kotecha, J, et al. (2011) Chronic constipation: an evidenced based review. J Am Board Fam Med 24, 436451.
25.Vandeputte, D, Falony, G, Vieira-Silva, S, et al. (2016) Stool consistency is strongly associated with gut microbiota richness and composition, enterotypes and bacterial growth rates. Gut 65, 5762.
26.Dimidi, E, Christodoulides, S, Fragkos, C, et al. (2014) The effect of probiotics on functional constipation in adults: a systematic review and meta-analysis of randomised controlled trials. Am J Clin Nutr 100, 10751084.
27.Stonehouse, W, Gammon, CS, Beck, K, et al. (2013) Kiwifruit: our daily prescription for health. Can J Physiol Pharmacol 91, 442447.
28.Zhao, Y & Yu, YB (2016) Intestinal microbiota and chronic constipation. SpringerPlus 5, 1130.
29.Wallace, A, Eady, S, Drummond, L, et al. (2017) A pilot randomised cross-over trial to examine the effect of kiwifruit on satiety and measures of gastric comfort in healthy adult males. Nutrients 9, 639.
30.Rome Foundation (2016) Rome IV Functional Gastrointestinal Disorders. Raleigh, NC: Rome Foundation. (accessed January 2016).
31.Rajindrajith, S, Devanarayana, NM & Benninga, MA (2017) Constipation and constipation predominant irritable bowel syndrome: a comparative study using Rome III criteria. J Paed Gastroenterol Nutr 64, 679684.
32.Rolls, BJ, Bell, EA, Castellanos, VH, et al. (1999) Energy density but not fat content of foods affected energy intake in lean and obese women. Am J Clin Nutr 69, 863887.
33.Rolls, BJ, Ello-Martin, JA & Tohill, BC (2004) What can intervention studies tell us about the relationship between fruit and vegetable consumption and weight management? Nutr Rev 62, 117.
34.Ministry of Health (2015). Eating and Activity Guidelines for New Zealand Adults. Wellington: Ministry of Health.
35.Shridhar, G, Rajendra, N, Murigendra, H, et al. (2015) Modern diet and its impact on human health. J Nutr Food Sci 5, 430433.
36.Thompson, FE, Subar, AF, Loria, C, et al. (2010) Need for technological innovation in dietary assessment. J Am Diet Assoc 110, 4851.
37.Dehghan, M, Akhtar-Danesh, N, McMillan, CR, et al. (2007) Is plasma vitamin C an appropriate biomarker of vitamin C intake? A systematic review and meta-analysis. Nutr J 6, 41.
38.Carr, AC, Pullar, JM, Moran, S, et al. (2012) Bioavailability of vitamin C from kiwifruit in non-smoking males: determination of ‘healthy’ and ‘optimal’ intakes. J Nutri Sci 1, e14.
39.Ranganathan, P, Pramesh, CS & Aggarwal, R (2016) Common pitfalls in statistical analysis: intention-to-treat versus per protocol analysis. Perspect Clin Res 7, 144146.
40.Liu, KS & Mager, D (2016) Women's involvement in clinical trials: historical perspective and future implications. Pharm Pract 14, 708.
41.Longstreth, GF, Thompson, WG, Chey, WD, et al. (2006) Functional bowel disorders. Gastroenterology 130, 14801491.
42.Lee, SY, Kim, JH, Sung, I, et al. (2007) Irritable bowel syndrome is more common in women regardless of the menstrual phase: a Rome II based survey. J Korean Med Sci 22, 851854.
43.Banks, I (2001) No man's land: men, illness and the NHS. Br Med J 323, 10581060.
44.Bazzano, LA, Joshipura, KJ, Li, TY, et al. (2008) Intake of fruit, vegetables and fruit juices and risk of diabetes in women. Diabetes Care 31, 13111317.



Altmetric attention score

Full text views

Total number of HTML views: 0
Total number of PDF views: 0 *
Loading metrics...

Abstract views

Total abstract views: 0 *
Loading metrics...

* Views captured on Cambridge Core between <date>. This data will be updated every 24 hours.

Usage data cannot currently be displayed